The company’s European arm, Medicaroid GmbH, announced the regulatory milestone on LinkedIn.

“We are proud to announce that the Hinotori surgical robot system has received CE-MDR approval in Europe,” the company wrote. “This marks an important milestone for Medicaroid and reflects the work of many dedicated teams who contributed their expertise and commitment along the way. Robotic-assisted surgery keeps moving forward, and we are proud to contribute to the advancement of minimally invasive surgery.”

Medicaroid said it aims to provide a wide range of robotics, not only in the surgical field but also for a wide range of healthcare functions.